Support Alert

Drug Safety Update: Levonogestrel-containing emergency hormonal contraception:

15 Sep 2016

Drug Safety Update: Levonogestrel-containing emergency hormonal contraception: advice on interactions with hepatic enzyme inducers 

The Medicines and Healthcare products Regulatory Agency (MHRA) have produced a drug safety update which includes revised advice on Levonorgestrel-containing emergency hormonal contraception.  This includes information for women seeking emergency contraception who have used CYP3A4 enzyme inducing drugs within the last 4 weeks.

For further information see the Drug Safety Update and RPS guidance on Oral Emergency Contraceptives as Pharmacy Medicines.

Loading...